Table 4 Multivariable Estimates of Absolute risk of an Acute Renal Adverse Event
Variable | Absolute Risk Estimate (95% confidence interval) | P-Value |
|---|---|---|
CT | 0.19% (0.17, 0.21%) | < 0.0001 |
Iodinated CM | 0.81% (0.80, 0.83%) | < 0.0001 |
CKD Stage 1 | 2.55% (2.35, 2.74%) | < 0.0001 |
CKD Stage 2 | 4.64% (4.56, 4.71%) | < 0.0001 |
CKD Stage 3 | 7.24% (7.19, 7.28%) | < 0.0001 |
CKD Stage 4/5 | 8.14% (8.08, 8.19%) | < 0.0001 |
Cancer | 0.87% (0.85, 0.89%) | < 0.0001 |
 Urinary | 2.33% (2.28, 2.39%) | < 0.0001 |
 Leukemia | 2.20% (2.09, 2.31%) | < 0.0001 |
 Colorectal | 1.69% (1.63, 1.75%) | < 0.0001 |
 Hemolymph | 1.22% (1.12, 1.33%) | < 0.0001 |
 Gynecological | 1.03% (0.95, 1.11%) | < 0.0001 |
 Liver | 1.00% (0.84, 1.16%) | < 0.0001 |
 Gastrointestinal | 0.59% (0.54, 0.65%) | < 0.0001 |
 Lung | 0.33% (0.27, 0.39%) | < 0.0001 |
 Endocrine | 0.29% (0.18, 0.39%) | < 0.0001 |